These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13245235)

  • 21. [Recurrent attacks of scarlet fever and penicillin treatment (author's transl)].
    Kucera H; Bauer P
    Wien Klin Wochenschr; 1974 Sep; 86(16):452-6. PubMed ID: 4428771
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of the scarlet fever vaccination from the clinical and immunological standpoint].
    HANSEN F; HEINTZEN P; HESELER E
    Monatsschr Kinderheilkd (1902); 1953 Mar; 101(3):205-7. PubMed ID: 13072296
    [No Abstract]   [Full Text] [Related]  

  • 23. [Purified adsorbed scarlet fever toxin. II. Adsorption of purified scarlet fever toxin].
    PAVLOV PV; AKIMOVA VV; PEMIANKEVICH AN
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):8-10. PubMed ID: 13605084
    [No Abstract]   [Full Text] [Related]  

  • 24. Properties of scarlet fever toxin of the NY5 strain.
    STOCK AH; VERNEY E
    J Immunol; 1952 Oct; 69(4):373-8. PubMed ID: 13000148
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of scarlet fever control; vaccination or penicillin treatment].
    REPLOH H; HANDLOSER M
    Medizinische; 1952 Dec; 20(51-52):1620-2. PubMed ID: 13024629
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the problem of active anti-scarlet fever immunization and its effect on angina morbidity].
    MITEL'MAN SL
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Apr; 32():53-5. PubMed ID: 13771372
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evolution of the antistreptolysin O titer in scarlet fever during prolonged penicillin therapy as compared with the clinical evolution].
    Buşilă VT; Sarlău A; Pintea L
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):347-59. PubMed ID: 5400035
    [No Abstract]   [Full Text] [Related]  

  • 28. Scarlet fever is caused by a limited number of Streptococcus pyogenes lineages and is associated with the exotoxin genes ssa, speA and speC.
    Silva-Costa C; Carriço JA; Ramirez M; Melo-Cristino J
    Pediatr Infect Dis J; 2014 Mar; 33(3):306-10. PubMed ID: 24168973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CLINICAL PICTURE AND PREVENTION OF RECURRENT SCARLET FEVER].
    ALISOV PA; KAZANTSEV AP
    Vopr Okhr Materin Det; 1963 Jul; 8():31-5. PubMed ID: 14069396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sensitizing properties of scarlet fever streptococcal allergen and toxin].
    KIRILENKO OA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Dec; (12):44-50. PubMed ID: 13300919
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems of immunologic characteristics in scarlet fever; dynamics of antistreptolysin and antifibrinolysin titers].
    KUZNETSOVA NM
    Vopr Pediatrii; 1953; 21(3):28-9. PubMed ID: 24542745
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sensitivity to penicillin and sulfonamide derivatives of 82 strains of Streptococcus hemolyticus isolated from the throat in scarlet fever].
    POUCHE A; CARLETTI B
    Minerva Pediatr; 1951 Oct; 3(10):534-7. PubMed ID: 14929149
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug sensitivity of hemolytic streptococci isolated from cases of scarlet fever treated with penicillin.
    HARTMAN TL; WEINSTEIN L
    Proc Soc Exp Biol Med; 1948 Nov; 69(2):314-6. PubMed ID: 18102216
    [No Abstract]   [Full Text] [Related]  

  • 34. Allergenic property of scarlatinal toxin.
    BOROFF DA
    J Bacteriol; 1951 Nov; 62(5):627-31. PubMed ID: 14897839
    [No Abstract]   [Full Text] [Related]  

  • 35. Does penicillin treatment of patients with scarlet fever affect the immunity.
    ANTTONEN VM
    Ann Paediatr Fenn; 1958; 4(1):30-41. PubMed ID: 13509412
    [No Abstract]   [Full Text] [Related]  

  • 36. [The passive hemagglutination test for detection of antibodies to scarlet fever toxin].
    Silich VA; Fiks LI; Cherkasskaia RS
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):57-62. PubMed ID: 4673601
    [No Abstract]   [Full Text] [Related]  

  • 37. Dick tests and localized reactions following intracutaneous injections of an erythrogenic toxin in student nurses.
    TODD RL
    J Lancet; 1947 Sep; 67(9):322. PubMed ID: 20259802
    [No Abstract]   [Full Text] [Related]  

  • 38. The antistreptolysin O titer in penicillin therapy of scarlet fever.
    WILDHACK R; RICHTER H; KIRBERGER E
    Arztl Wochensch; 1954 Nov; 9(46):1090-2. PubMed ID: 13206911
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic serum concentrations of penicillin.
    Huenbner RA
    J Am Vet Med Assoc; 1971 Sep; 159(6):757-9. PubMed ID: 5168372
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antitoxic immunity and allergic reactions in scarlet fever in various seasons; regional characteristics of the development of antitoxic immunity in scarlet fever].
    MUSABAEV IK; KHAMIDOV SKh
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):64-7. PubMed ID: 13282459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.